FDA Center for Drug Evaluation & Research Issues Warning Letter to Tianjin Kilo Pharmaceutical Sci-tech
August 19, 2026
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Tianjin Kilo Pharmaceutical Sci-tech Co. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Wenjun Liao, General Manager, Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd., Room 609, Building 6, no. 6 Ziyuan Road, Huayuan High-tech Industrial Park Tianjin Shi, 300384, China, (b)(4)
Issuing Office: Cent . . .
* * *
Recipient: Wenjun Liao, General Manager, Tianjin Kilo Pharmaceutical Sci-tech Co., Ltd., Room 609, Building 6, no. 6 Ziyuan Road, Huayuan High-tech Industrial Park Tianjin Shi, 300384, China, (b)(4)
Issuing Office: Cent . . .
